7-92517373-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000466.3(PEX1):c.1142C>A(p.Ala381Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 1,613,242 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A381G) has been classified as Likely benign.
Frequency
Consequence
NM_000466.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PEX1 | NM_000466.3 | c.1142C>A | p.Ala381Asp | missense_variant | 5/24 | ENST00000248633.9 | |
PEX1 | NM_001282677.2 | c.1142C>A | p.Ala381Asp | missense_variant | 5/23 | ||
PEX1 | NM_001282678.2 | c.518C>A | p.Ala173Asp | missense_variant | 5/24 | ||
PEX1 | XM_047420472.1 | c.1142C>A | p.Ala381Asp | missense_variant | 5/23 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PEX1 | ENST00000248633.9 | c.1142C>A | p.Ala381Asp | missense_variant | 5/24 | 1 | NM_000466.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00749 AC: 1137AN: 151754Hom.: 14 Cov.: 32
GnomAD3 exomes AF: 0.00180 AC: 452AN: 251376Hom.: 4 AF XY: 0.00131 AC XY: 178AN XY: 135872
GnomAD4 exome AF: 0.000770 AC: 1125AN: 1461370Hom.: 11 Cov.: 33 AF XY: 0.000704 AC XY: 512AN XY: 727038
GnomAD4 genome ? AF: 0.00749 AC: 1137AN: 151872Hom.: 14 Cov.: 32 AF XY: 0.00674 AC XY: 500AN XY: 74196
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 29, 2016 | - - |
Zellweger spectrum disorders Benign:2
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Jun 30, 2017 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Nov 23, 2015 | - - |
Peroxisome biogenesis disorder 1A (Zellweger) Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at